⌕
Vera Therapeutics · VERA · Nasdaq
Tenet 41 · Weak
Compare
$26.20−2.85%At closeTenet 41 · Weak
$26.20−0.77 (−2.85%)
At close: Nov 17, 2026, 4:00 PM ET· Nasdaq · USD

Vera Therapeutics (VERA) Institutional Ownership

13F filers reported holding 18.5% of Vera Therapeutics (VERA) shares as of Sep 30, 2026, across 91 filers.

Sources Ownership filingsQuarter ended How we compute thisNot investment advice
Held by 13F filers
18.5%
Sep 30, 2026
13F filers
91
quarter ended Sep 30, 2026
13F value
$432.9M
13.4M shares
Quarter's fund flow
Mild accumulation
15 new · 10 closed

Is the smart money (institutions and insiders) accumulating or distributing? One lagging input, not a buy signal.

13F fund flowQuarter ended Sep 30, 2026: more funds added or entered than trimmed or exited, mild accumulation (15 new · 36 increased · 25 reduced · 10 closed · 5 unchanged or with no prior quarter on file). Flows at this scale move slowly; treat as context. These positions are 49 days old; the 45-day figure often quoted is the SEC filing deadline after quarter-end, not the age of the data. The counts above compare each filer’s position with its own previous 13F. The change in the number of filers and in the ownership share is not shown: the filings we read hold only each filer’s latest 13F, so there is no earlier quarter of the same filers to compare against. That is a limit of the source, not a statement about this company.
Basis: shares reported by 91 13F filers for Sep 30, 2026, over shares outstanding implied from the current quote, measured 49 days apart. It measures the ownership we have filings for, not total institutional ownership, and it moves with the share count between filings.
routine sells are usually compensation mechanics; open-market buys are the rarer signal. Rows labelled with another security are the derivative leg of a vest or exercise, not share sales
DateNameRoleTypeSharesPriceSEC filing
Sep 11, 2026Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCRAcquired · Option exercise5,000$3.94↗
Sep 11, 2026Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCRDisposed · Option exercise5,000Stock Option (right to buy)—↗
Sep 2, 2026Fordyce MarshallPRESIDENT AND CEOAcquired · Option exercise18,500$2.90↗
Sep 2, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale18,500$35.12↗
Sep 2, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Option exercise18,500Stock Option (Right to Buy)—↗
Aug 3, 2026Boman Nancy LeeChief Regulatory OfficerAcquired · Grant / award44,987—↗
Aug 3, 2026Boman Nancy LeeChief Regulatory OfficerAcquired · Grant / award63,011Stock Option (right to buy)—↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEOAcquired · Option exercise46,250$2.90↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale1,000$40.78↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale32,550$42.07↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale10,500$42.86↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale2,200$43.59↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Option exercise46,250Stock Option (Right to Buy)—↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale1,000$40.78↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale32,550$42.07↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale10,500$42.86↗
Jul 7, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale2,200$43.59↗
Jun 23, 2026Fordyce MarshallPRESIDENT AND CEOAcquired · Option exercise18,500$2.90↗
Jun 23, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale18,412$37.93↗
Jun 23, 2026Fordyce MarshallPRESIDENT AND CEODisposed · Open-market sale88$38.43↗

* Holdings as reported for Sep 30, 2026, 49 days old; funds file up to 45 days after each quarter-end, so the newest complete quarter runs 45 to 135 days behind.

** A price of “—” marks an option exercise, RSU vest or a filing without a usable per-share price, not a $0 trade.

How much of Vera Therapeutics do institutions hold?

13F filers reported holding 18.5% of Vera Therapeutics' shares as of Sep 30, 2026, across 91 filers.

How many 13F filers hold Vera Therapeutics?

Vera Therapeutics was held by 91 13F filers as of Sep 30, 2026.

Not investment advice.

Install Tenet on your phone

Tenet home pageMethodology© 2026 Tenet Investing Inc.

Data from Intrinio and Financial Modeling Prep.